Dove Medical Press Ltd., a division of Taylor & Francis, has partnered with The Charlesworth Group to integrate its manuscript submission system into Charlesworth's WeChat Gateway platform. The use of WeChat within the scientific community in China continues to grow and has over-taken email as the preferred primary communication channel for China-based academic authors.
By integrating their submission system directly into Charlesworth's Gateway, Dove can now support its China-based academic authors 24/7.
The 'Gateway' is Charlesworth's proprietary technology platform. It acts as a hub, receiving manuscript status data via API from Dove's manuscript submission system and then personalising that data and transmitting it to Dove's WeChat account. The platform's statistics provide real-time data on the number and growth of Dove Medical's WeChat followers. It also reports on followers' engagement with Dove's WeChat marketing content.
The integration allows Dove to continually engage with their authors and enhance their experience by providing paper status notifications directly to authors' phones via the Gateway's chatbot. The use of the chatbot ensures an efficient service, giving responses to the most commonly asked author queries in a matter of seconds.
Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.
